1,3-Dibutylxanthine → Diethyl [3-(1,3-dipropylxanthin-7-yl)propyl]phosphonate

HRID 2004

반응식

HRID 2004 반응식
[CH2:1]([N:5]1[C:14](=[O:15])[C:13]2[NH:12][CH:11]=[N:10][C:9]=2[N:8]([CH2:16][CH2:17][CH2:18]C)[C:6]1=[O:7])[CH2:2][CH2:3]C.Br[CH2:21][CH2:22][CH2:23][P:24]([O:29][CH2:30][CH3:31])(=[O:28])[O:25][CH2:26][CH3:27]>>[CH2:1]([N:5]1[C:14](=[O:15])[C:13]2[N:12]([CH2:21][CH2:22][CH2:23][P:24](=[O:28])([O:29][CH2:30][CH3:31])[O:25][CH2:26][CH3:27])[CH:11]=[N:10][C:9]=2[N:8]([CH2:16][CH2:17][CH3:18])[C:6]1=[O:7])[CH2:2][CH3:3]

참가 물질

3

실험 절차

The title substance was prepared from 1,3-dibutylxanthine and diethyl 3-bromopropanephosphonate analogously to Example 9.

출처 및 근거

ORD 기록
ord-aa87420356fe4ddca1dff1d5942c9cf8
출처 데이터셋
uspto-grants-1998_03
특허 번호
US05728686

연결된 노트

불러오는 중…